Proactive Australia

After Market

Business EN ↓ 20 episodes

Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse. Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals. Please note that the views of our interviewees are not the views of Proactive Investors. Seek independent investment advice before making any financial decisions and remember that nothing you hear on this pod constitutes investment advice.

Be sure to visit the podcast's website and support the creator: after-market.simplecast.com

Author

Proactive Australia

Category

Business

Podcast website

after-market.simplecast.com

Latest episode

Jun 4, 2025

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

ASX companies turn to OTC Markets for dual listing 04.06.2025

In this episode, OTC Markets Group executive vice president Jason Paltrowitz joins Proactive to discuss how international companies—especially those listed on the Australian Securities Exchange (ASX)—can efficiently expand their reach to United States investors through secondary trading on OTC Markets. Paltrowitz explains the challenges U.S. investors face when trying to access equities listed on...

Safer chemotherapy? Race Oncology’s new drug heads to trials 28.03.2025

Race Oncology Ltd is advancing the development of a reformulated chemotherapy drug aimed at reducing severe side effects, particularly cardiac-related risks, while preserving or improving efficacy. In this episode of After Market with Jonathan Jackson, CEO and managing director Daniel Tillett highlighted the drug’s potential to work alongside anthracyclines, a common class of chemotherapy agents,...

The state of drug development in Australia: a case study 28.05.2024

Amplia Therapeutics Ltd CEO and managing director Dr Chris Burns has had a long career in drug development, including discovering only the second Australian drug to receive US FDA approval. He has plenty of advice to share for Australian-based researchers and domestically developed biotech assets. Proactive's Susanna Nelson chats to him about the current state of clinical research and commercial d...

Australian Vanadium reinforces potential for long-lasting, high-grade vanadium and battery metal project 14.03.2024

Australian Vanadium Ltd (ASX:AVL) CEO Graham Arvidson sits down with Proactive’s Jonathan Jackson to discuss progress in the company's metallurgical testing following a recent merger with Technology Metals Australia Ltd (TMT). AVL plans to capitalise on the battery metal boom with its vanadium and high-grade iron project, leveraging its subsidiary VSUN to build out the Vanadium Flow Battery market...

Carbon capture and storage: An essential part of the circular economy 13.02.2024

How can resource companies mitigate their carbon emissions in innovative ways? Proactive’s Phoebe Shields talks to CSIRO’s Dr Dia Milani, who leads the organisation’s CO2 utilisation team within the Sustainable Carbon Technologies group, about the urgency of including carbon capture and storage methods in the mix of tools to combat climate change – and the opportunities that abound for companies t...

Artemis Resources is chasing gold, copper and lithium in the Pilbara 05.01.2024

Artemis Resources Ltd executive director George Ventouras talks to Proactive’s Susanna Nelson about the company’s projects, mostly in the West Pilbara, where it is exploring for gold, copper and lithium. George also weighs in on ‘the white gold boom’, the importance of a diverse and sustainable mining industry to the Australian economy and the future of mining in this country.

How does Australia get the best out of its relationship with China? 04.12.2023

China is our biggest trading partner. In this introduction to the topic, mining publisher and China entrepreneur Yolanda Torrisi tells Proactive about the Australian industries that are most exposed to the trading giant, whether diplomatic relations are starting to defrost, and how we can leverage the relationship to our best advantage at a time of uncertainty for global markets and supply chains.

Provaris an early mover on green hydrogen supply chain in Europe 17.11.2023

Energy security is critical in these days of geopolitical unrest. Provaris Energy Ltd has seen the writing on the wall and has forged ahead with its business model of simple and efficient hydrogen production and transportation. MD and CEO Martin Carolan tells Proactive's Susanna Nelson the company is currently in the design phase of a prototype tank for compressed hydrogen, with construction and t...

Moving clinical trials out of the hospital and into general practice 07.11.2023

Clinical trials are, by necessity, subject to rigorous guidelines to protect human health. Proactive’s Phoebe Shields talks to Evrima founder and CEO Charlotte Bradshaw about her company’s data-driven patient matching system, which verifies and matches participants’ electronic medical records to trial protocols. This breaks down barriers to trial recruitment such as awareness, hospital-centricity,...

Imugene forges ahead with VAXINIA trial targeting solid tumours 03.11.2023

Clinical-stage immuno-oncology biotech Imugene has been making significant strides in the development of therapies targeting a range of cancers. In this episode of After Market, MD and CEO Leslie Chong tells Susanna Nelson about the company's Phase 1 metastatic advanced solid tumours, or MAST, trial, which has been designed to evaluate the safety and efficacy of the cancer-killing virus CF33-hNIS...

Building a diverse portfolio during economic uncertainty 02.10.2023

The last few years have seen investors buffeted by the winds of pandemic and war, bringing with them supply chain issues, overcooked inflation and much-dreaded rate hikes. Atrium senior portfolio manager Brendan Paul talks to Proactive about why it’s an interesting time to be an investor, what risk really means and the importance of building a truly diverse asset portfolio in uncertain times.

Antimicrobial resistance and the coming plague 29.08.2023

Antimicrobial resistance means the age of antibiotics – when humanity has had the luxury of fixing or preventing all manner of disease with a simple biological agent in a capsule – is coming to an end. Recce Pharmaceuticals CEO James Graham talks to Proactive’s Susanna Nelson about how we stay one step ahead in the fight against deadly pathogens and avoid the next superbug.

Australia's green critical mineral opportunity 31.07.2023

The critical mineral boom is taking off. CSIRO senior principal research scientist and Green Mineral Technologies initiative leader Chris Vernon walks Proactive’s Phoebe Shields through the oncoming critical mineral supply dearth, the need for down-stream trade relationships and the potential effect of a circular economy on the mining industry.

Cannabis and psychedelic regulation in Australia 27.06.2023

What are the rules governing cannabis and psychedelics in Australia? How have attitudes to these substances changed over time, and what does the Australian biotech industry need governments to do to unlock the myriad therapeutic benefits they promise? Emyria's Dr Michael Winlo answers these questions and more in this interview with Proactive's Susanna Nelson.

How AI is changing the way we do business 31.05.2023

With AI all over news, it’s hard to sort out the opportunity from the threat. Avanade’s Warwick Talbot tells Proactive’s Phoebe Shields about the business potential presented by digitisation, machine learning’s use in data curation and real time insights, and the emergence of the industrial metaverse and digital twinning.

The interplay between indigenous rights and mining 31.05.2023

Long-time indigenous policy maker and advocate Ian Hamm chats to Proactive’s Susanna Nelson about the complex interplay between mining and Aboriginal rights over time. Ian argues for a seat at the board table for Aboriginal and Torres Strait Islander Peoples and expresses his hope that the looming referendum on the Voice to Parliament will usher in a period of genuine change.

The electric vehicle landscape in Australia 31.05.2023

Australian Electric Vehicle Association president Dr Chris Jones discusses the past, present and future of electric vehicles with Proactive’s Phoebe Shields, with insights from his own career in academia and as a change maker. What will be needed to bring about a change in attitudes toward the transportation of the future in Australia, and how do we achieve it?

Calculated risk in the battery metals market 31.05.2023

Riversgold Ltd CEO Julian Ford talks to Proactive’s Phoebe Shields about the importance of the current battery minerals rush, and describes his journey from Apartheid South Africa to Australia and how it shaped his attitude to work, life and mining. A troubleshooter by nature, Ford looks for solutions, and there is none more pressing than the need to ramp up critical minerals production at a time...

Critical minerals mining and the social contract 31.05.2023

Lightning Minerals CEO Alex Biggs tells Proactive’s Phoebe Shields about his eventful early life, personal hardship and eventual foray into critical minerals mining. Alex explains how his background has informed his personal philosophy and why resilience, integrity and a commitment to the social contract is key to his understanding of why he does what he does.

After Market - Trailer 25.05.2023

Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse. Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals. Please note that the views of our interviewees are not the views of Proactive Investors. Seek in...

Listen to the After Market podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.